Friday, 26 May 2017

New Zealand News

  • Invida gets COPD drug rights in Australia, NZ

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Almirall granted commercial rights for Aclidinium in Australia and New Zealand for the treatment of chronic obstructive pulmonary disorder (COPD) to Invida Holdings. Although th...Read more

  • Pictor launches 5-in-1 infant testing kit in India

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: More than 300,000 babies die within the first 24 hours of being born in India every year, according to the latest State of the World's Mothers Report from Save The Children. An i...Read more

  • Allon neuro protein gets US, NZ, Mexico patent

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Allon Therapeutics received composition of matter patents from the US, New Zealand and Mexico for a new family of peptides that the company believes has the potential to be deve...Read more

  • Health committee gives suggestion to boost NZ's choking clinical trials sector

    New Zealand |  Analysis | By Vipul Murarka | 0 Comment

    New Zealand's Health Committee submitted a 62-page report to New Zealand's Parliament making necessary recommendations to improve the existing clinical trials industry. The committee made 5...Read more

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    New Zealand |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • Medigene, SynCore expand deal for Veregen

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and supply contract into new re...Read more

  • Aus, NZ progress on joint regulatory agency

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic Products Agency (ANZTPA) implementation ministerial council in a con...Read more

  • Dr Frances Guyett to head NZ innovation hub

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: New Zealand Health Innovation Hub has appointed Dr Frances Guyett as its chief executive. "After an extensive international search, I am delighted to announce the appointment of ...Read more

  • Real-Time Location Systems are a big hit in Asia

    New Zealand |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: Rising costs are compelling hospitals in South East Asia, Australia and New Zealand (ANZ) to streamline their operations, which, in turn, is opening up several opportunities for ...Read more

  • NZ firm to raise funds for Australia trial

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • LanzaTech secures $15 mn debt financing from WTI

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: LanzaTech, a pioneer in waste-to-fuels and chemicals technology, closed $15 million in debt financing from Western Technology Investment (WTI), a private investment firm based i...Read more

  • Asia vaccine strategists call for collaboration

    New Zealand |  News | By Amrita Tejasvi | 0 Comment

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • Clinical Network Services acquires Beltas' assets

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the planning, implementation and delivery of phase I and II trials, has acquir...Read more

  • Clinical Network Services acquires BELTAS' business assets

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealand partner BELTAS, a CRO based in Auckland. Terms of the deal were not...Read more

  • LanzaTech wins TiE50 award

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from waste gases, has for the second year in a row been named in the TiE50 as a leader in entrepreneurship, innovation, an...Read more

  • 5 major policy developments of 2012

    New Zealand |  Regulatory | By BioSpectrum Bureau | 0 Comment

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • What the future holds for the APAC CRO market?

    New Zealand |  Analysis | By BioSpectrum Bureau | 0 Comment

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Trial begins for vaccine that builds gluten tolerance

    New Zealand |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls